CPC A61K 38/29 (2013.01) [A61K 9/0019 (2013.01); A61K 47/54 (2017.08); A61K 47/545 (2017.08); A61K 47/60 (2017.08)] | 9 Claims |
1. A method of treating a patient having hypoparathyroidism comprising administering to the patient a therapeutically effective amount of a compound according to formula 31
![]() or a pharmaceutically acceptable salt thereof, thereby treating hypoparathyroidism in the patient,
wherein PTH(1-34) is parathyroid hormone of the amino acid sequence SEQ ID NO:51, NαS1 is the alpha amino group of the N-terminal serine of SEQ ID NO:51 and 2×10 kDa PEG comprises a branched polyethylene glycol polymer of two arms in which each arm has a molecular weight of about 10 kDa and is a moiety of formula (b)
![]() wherein the dashed line indicates attachment to —S— in compound 31, and each of m and p of each moiety is independently an integer.
|